ENDEMIC DISEASE AND DEVELOPMENT - THE LEISHMANIASES

被引:32
|
作者
WIJEYARATNE, PM
ARSENAULT, LKJ
MURPHY, CJ
机构
[1] Health Sciences Division, International Development Research Centre, MDRC, Ottawa
关键词
TROPICAL DISEASE; LEISHMANIASIS; DEVELOPMENT; COMMUNITY SOCIAL; ENVIRONMENT;
D O I
10.1016/0001-706X(94)90106-6
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Health and sustainable development are intricately interwoven. Communities under pressure from a barrage of endemic diseases face tremendous obstacles in achieving an improved quality of life. The leishmaniases are examples of hitherto underestimated parasitic zoonoses which place those communities affected at significant risk of morbidity, debility and mortality. This article summarizes the experience of community-based applied research projects on leishmaniasis supported by the Canadian International Development Research Centre, in Lebanon, Jordan, Ethiopia, Kenya, Tunisia, Mexico, Costa Rica, Colombia, Peru, and Brazil. The article examines the role of leishmaniasis-associated morbidity versus mortality, and the impact of these diseases on a community's capacity to develop. It further analyzes the various determinants of leishmaniasis infection, disease and outcomes, and their interactions at the individual as well as the community level. Adverse health implications as a result of external and intervening factors are examined. Such factors include ecological/environmental changes such as those arising from developmental projects, unplanned urbanization, and continuous movements of populations. The paper views strategies for prevention and control of leishmaniases in the context of socio-political and economic constraints of the affected countries. Particularly emphasized is the need to take into account the knowledge base, beliefs, perceptions and practices of the population by incorporating active community participation in preventative and intervention practices. Leishmaniasis poses a particular challenge to classical health systems that tend to resist innovative change needed to address socio-political and economic realities of the present and future decades.
引用
收藏
页码:349 / 364
页数:16
相关论文
共 50 条
  • [41] Epidemiology of autochthonous leishmaniases in France
    Dedet, Jean-Pierre
    Carme, Bernard
    Desbois, Nicole
    Bourdoiseau, Gilles
    Lachaud, Laurence
    Pratlong, Francine
    PRESSE MEDICALE, 2013, 42 (11): : 1469 - 1481
  • [42] Leishmaniases in the XXI century - Portugal
    Maia, C.
    Cortes, S.
    Afonso, M. O.
    Campino, L.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 171 - 171
  • [43] Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
    Monteiro, Lis Marie
    Lobenberg, Raimar
    Cotrim, Paulo Cesar
    Barros de Araujo, Gabriel Lima
    Bou-Chacra, Nadia
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [44] One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools
    Hong, Ahyun
    Zampieri, Ricardo Andrade
    Shaw, Jeffrey Jon
    Floeter-Winter, Lucile Maria
    Laranjeira-Silva, Maria Fernanda
    PATHOGENS, 2020, 9 (10): : 1 - 24
  • [45] MACROETHICS AND ENDEMIC DISEASE
    DICKENS, BM
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 1992, 34 : S2 - S5
  • [46] The leishmaniases in Kenya: A scoping review
    Grifferty, Grace
    Shirley, Hugh
    O'Brien, Katherine V.
    Hirsch, Jason E.
    Orriols, Adrienne
    Amechi, Kiira Lani
    Lo, Joshua
    Chanda, Neeharika
    El Hamzaoui, Sarra
    Kahn, Jorja
    Yap, Samantha L.
    Watson, Kyleigh
    Curran, Christina L.
    Atef AbdelAlim, Amina
    Bose, Neeloy L.
    Cilfone, Alissa Link
    Wamai, Richard L.
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (06):
  • [47] Cytokines in the immunity and immunopathogenesis in leishmaniases
    Saha, Bhaskar
    Silvestre, Ricardo
    CYTOKINE, 2021, 145
  • [48] The leishmaniases as emerging and reemerging zoonoses
    Ashford, RW
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2000, 30 (12-13) : 1269 - 1281
  • [49] Leishmaniases in Northern Greece: seroprevalence of the infection and incidence of the disease during the period 2001–2006
    E. Diza
    A. Kansouzidou
    S. Gerou
    E. Vezyri
    S. Metallidis
    A. Antoniadis
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 997 - 1003
  • [50] Review of the current treatments for leishmaniases
    Lauletta Lindoso, Jose Angelo
    Lopes Costa, Jackson Mauricio
    Queiroz, Igor Thiago
    Goto, Hiro
    RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2012, 3 : 69 - 77